Companies

LEXICON PHARMACEUTICALS, INC. (LXRX) SEC filings

CIK 0001062822 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)49.8 M139000
Net income (USD)-50.3 M-101.9 M
Diluted EPS (USD/shares)-0.14-0.62

Latest filings

FiledFormDescriptionPeriod
2026-08-14EFFECTEFFECT items ,,
2026-08-06S-3S-3
2026-08-06S-8S-8
2026-08-0610-Q10-Q2026-06-30
2026-08-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-06-044PRIMARY DOCUMENT2026-06-03
2026-05-08442026-04-30
2026-05-08SCHEDULE 13D/ASCHEDULE 13D/A
2026-05-0710-Q10-Q2026-03-31
2026-05-078-K8-K items 2.02,9.012026-05-07
2026-05-068-K8-K items 1.01,2.03,3.02,7.01,9.012026-05-04
2026-05-044PRIMARY DOCUMENT2026-05-01
2026-05-044PRIMARY DOCUMENT2026-05-01
2026-05-044PRIMARY DOCUMENT2026-05-01
2026-05-044PRIMARY DOCUMENT2026-05-01
2026-05-044PRIMARY DOCUMENT2026-05-01
2026-05-044PRIMARY DOCUMENT2026-05-01
2026-05-044PRIMARY DOCUMENT2026-05-01

Forms on file (last 1,000): 4 488, 8-K 180, 10-Q 50, 3 26, SC 13G/A 26, SC 13D/A 20, DEFA14A 18, DEF 14A 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=LXRX (0.002 USD), /gw/filings/filings?ticker=LXRX&form=8-K, /gw/filings/facts?ticker=LXRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange